PCM
SAGE

Polymer Capital Management’s Sage Therapeutics SAGE Stock Holding History

Polymer Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,157
Closed -$384K – 925
2025
Q2 		$384K Buy
+42,157
New +$310K 0.05% 365

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polymer Capital Management's SAGE Position: Q3 2025 in Review

Polymer Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 42,157 shares — an estimated $384K sold.

Polymer Capital Management first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $384K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Polymer Capital Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Polymer Capital Management sold 42,157 Sage Therapeutics shares in Q3 2025, an estimated $384K.
  • Polymer Capital Management first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Polymer Capital Management's Sage Therapeutics position peaked at $384K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Polymer Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.